Lastly we should have that info in the not too distant future, we are just waiting on the ethics committee approval for the last couple of patients.
The question below was asked and answered directly after the the Phase One top Line Results Presentation.
here https://investorhub.pharmaust.com/announcements/621921809:17AM 01/03/2024
Dr Thurn thankyou for the fantastic presentation.
My question is about the patients.
All 12 have chosen to continue to take Monepantel on compassionate grounds which is also fantastic, my best wishes are with them. It would give us a fair indication on how they have been going if the start point on the Rate of Decline of ALSFRS-R chart (slide5) for the new Fight MND open ended trial was available.
Are you able to share that info.
Paul
PharmAust
ASX:PAA01:20PM 01/03/2024
Hi Paul, Thanks for your question. The Open-label extension study is not funded by FightMND as it falls outside of its current funding opportunities. PharmAust is fully-funding that study. We will approach FightMND for further supplemental support given its success. In terms of supplying the start point for their ALSFRS-R score we can certainly look into that once all patients have been successfully enrolled into the study as the average score. Cheers Michael
- Forums
- ASX - By Stock
- Mainstream media is GO
Lastly we should have that info in the not too distant future,...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
0.015(8.82%) |
Mkt cap ! $82.65M |
Open | High | Low | Value | Volume |
17.5¢ | 18.5¢ | 17.5¢ | $110.2K | 620.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 300901 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 183662 | 0.175 |
4 | 105394 | 0.170 |
2 | 287747 | 0.165 |
5 | 354112 | 0.160 |
9 | 210434 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 202500 | 5 |
0.190 | 196600 | 3 |
0.195 | 260704 | 8 |
0.200 | 1145496 | 13 |
0.205 | 122000 | 1 |
Last trade - 10.11am 26/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online